Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Deoxyribose phosphorothioate (5-tct-ccc-agc-gtg-cgc-cat-3)

EU orphan designation number: EU/3/01/063
Active ingredient: Deoxyribose phosphorothioate (5´-tct-ccc-agc-gtg-cgc-cat-3´)
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2001 Centralised Orphan - Designation EMEA/OD/025/01 (2001)3574 of 20/11/2001
07/01/2003 Centralised Orphan - Transfer of orphan designation EMEA/OD/025/01/T/01 (2002)5515 of 06/01/2003
28/07/2005 Centralised Orphan - Transfer of orphan designation EMEA/OD/025/01/T/01 (2005)2941 of 26/07/2005
01/12/2005 Other procedure
15/03/2013 Centralised Orphan - Removal of orphan designation from Community Register